Molecular markers of cancer stem cells verified in vivo

   
Kim Y.S.1 , Kaidina A.M.1, Chiang J.H.2, Yarygin K.N.1, Lupatov A.Yu.1

1. Institute of Biomedical Chemistry, Moscow, Russia
2. National Cheng Kung University, Tainan City, Taiwan
Section: Review
DOI: 10.18097/PBMC20166203228      UDK: 616.006; 577.29      PubMed Id: 27420613
Year: 2016  Volume: 62  Issue: 3  Pages: 228-238
This systematic review aims to analyze molecular markers of cancer stem cells. Only studies that confirmed tumor-initiating capacity of this population by in vivo assay in immunodeficient mice were included. Final sample of papers that fully correspond with initial aim consists of 97 original studies. The results of their analysis reveal that markers commonly used for cancer stem cells deriving were as follows: CD133, СD44, ALDH, CD34, CD24 and EpCAM. The review also contains description of molecular features of some cancer stem cell markers, modern approaches to cancer treatment by targeting this population and brief assessment of cancer stem cell theory development.
Download PDF:
Supplementary materials:
Reference:

Kim Y.S., Kaidina A.M., Chiang J.H., Yarygin K.N., Lupatov A.Yu. (2016) Biomeditsinskaya khimiya, 62(3), 228-238.
This paper is also available as the English translation:10.1134/S1990750817010036
References  
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)
        

© Institute of Biomedical Chemistry, Moscow, Russia